CA2386534C - Forme cristalline ii de la clarithromycine et son utilite - Google Patents

Forme cristalline ii de la clarithromycine et son utilite Download PDF

Info

Publication number
CA2386534C
CA2386534C CA002386534A CA2386534A CA2386534C CA 2386534 C CA2386534 C CA 2386534C CA 002386534 A CA002386534 A CA 002386534A CA 2386534 A CA2386534 A CA 2386534A CA 2386534 C CA2386534 C CA 2386534C
Authority
CA
Canada
Prior art keywords
methylerythromycin
peaks
powder
ray diffraction
values
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA002386534A
Other languages
English (en)
Other versions
CA2386534A1 (fr
Inventor
Jih-Hua Liu
David A. Riley
Stephen G. Spanton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BGP Products Operations GmbH
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4163180&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2386534(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Priority claimed from CA002258606A external-priority patent/CA2258606C/fr
Publication of CA2386534A1 publication Critical patent/CA2386534A1/fr
Application granted granted Critical
Publication of CA2386534C publication Critical patent/CA2386534C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

La présente invention concerne le nouvel antibiotique 6-O-méthylérythromycine A sous forme cristalline I, un procédé de fabrication, des compositions pharmaceutiques contenant ce composé et une méthode d'utilisation comme agent thérapeutique.
CA002386534A 1997-07-25 1997-07-25 Forme cristalline ii de la clarithromycine et son utilite Expired - Lifetime CA2386534C (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002258606A CA2258606C (fr) 1996-07-29 1997-07-25 Forme cristalline ii de la clarithromycine

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002258606A Division CA2258606C (fr) 1996-07-29 1997-07-25 Forme cristalline ii de la clarithromycine

Publications (2)

Publication Number Publication Date
CA2386534A1 CA2386534A1 (fr) 1998-02-05
CA2386534C true CA2386534C (fr) 2003-05-27

Family

ID=4163180

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002386534A Expired - Lifetime CA2386534C (fr) 1997-07-25 1997-07-25 Forme cristalline ii de la clarithromycine et son utilite

Country Status (1)

Country Link
CA (1) CA2386534C (fr)

Also Published As

Publication number Publication date
CA2386534A1 (fr) 1998-02-05

Similar Documents

Publication Publication Date Title
CA2258606C (fr) Forme cristalline ii de la clarithromycine
AU2001222619C1 (en) Processes for preparing clarithromycin polymorphs
CA2277274C (fr) Forme crystalline 0 de clarithromycine
AU783055B2 (en) Processes for preparing clarithromycin polymorphs and novel polymorph IV
US5844105A (en) Preparation of crystal form II of clarithromycin
AU733646B2 (en) Preparation of crystal form II of clarithromycin
CA2386534C (fr) Forme cristalline ii de la clarithromycine et son utilite
CA2386527C (fr) Forme cristalline i de la clarithromycine
CA2488397C (fr) Forme cristalline ii de la clarithromycine
AU777612B2 (en) Crystal form I of clarithromycin
HK1089182A (en) Crystal form i of clarithromycin
ZA200204638B (en) Processes for preparing clarithromycin polymorphs and novel polymorph IV.
AU2005203314A1 (en) Processes for preparing clarithromycin polymorphs

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20170725